Key regions: Australia, Italy, France, South Korea, Brazil
The Austrian healthcare system is one of the most efficient in the world, with universal coverage and a high standard of care. The Vaccines market in Austria is a growing sector within the healthcare industry, with an increasing demand for vaccinations among the population.
Customer preferences: Austrian customers are becoming more aware of the importance of vaccines in preventing diseases and are willing to pay for them. The demand for vaccines is driven by the increasing prevalence of infectious diseases, as well as the growing awareness of the benefits of vaccination. Customers are also looking for convenient and accessible vaccination services, which has led to the expansion of vaccination centers and clinics across the country.
Trends in the market: The Vaccines market in Austria is expected to grow over the next few years, driven by the increasing prevalence of infectious diseases and the growing demand for vaccines. The market is also being shaped by the introduction of new vaccines and the expansion of vaccination programs. The COVID-19 pandemic has also had a significant impact on the market, with the government investing in vaccine development and distribution to combat the virus.
Local special circumstances: Austria has a well-established healthcare system, which has played a key role in the development of the Vaccines market. The country has a high vaccination rate, with the government providing free vaccinations for a range of diseases. The country also has a strong pharmaceutical industry, with a number of local and international companies operating in the market.
Underlying macroeconomic factors: The Vaccines market in Austria is influenced by a range of macroeconomic factors, including government policies, healthcare spending, and population demographics. The government's commitment to universal healthcare and disease prevention has been a key driver of the market, with significant investment in vaccination programs and research. The aging population is also contributing to the growth of the market, as older adults are more susceptible to infectious diseases and require more vaccinations. The overall economic growth of the country is also a factor, as a strong economy can support increased healthcare spending and investment in the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
